^
Association details:
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
New
Title:

Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non–small-cell Lung Cancer Exhibiting Resistance to Ceritinib

Excerpt:
In summary, the G1123S mutation was identified in a patient with ALK+ non–small-cell lung cancer exhibiting resistance to ceritinib.
DOI:
10.1097/JTO.0000000000000509